Anavex Life Sciences Corp. (AVXL) was Initiated by Noble Financial to “Buy” and the brokerage firm has set the Price Target at $16. Noble Financial advised their Clients and Investors in a research report released on Feb 7, 2017.
Several company insiders have filed Insider transactions , on Jul 14, 2015, Christopher U Missling (CEO) purchased 1,000 shares at $0.52 per share price.
Anavex Life Sciences Corp. closed down -0.03 points or -0.52% at $5.72 with 9,56,624 shares getting traded on Friday. Post opening the session at $5.77, the shares hit an intraday low of $5.61 and an intraday high of $5.9 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.